Israelis bringing miraculous cancer-killing tech to market

For many years, one of the world's top scientists, synthetic organic chemist James Tour, has led a team developing next-generation "nanomachine" technology to target and kill cancer cells with virtually no side effects.

The use of that technology to treat cancer and other diseases is closer to reality now, with the launch of an Israeli company called Nanorobotics.

Therapies, though perhaps six years from the market, are now in the pre-clinical trial stage for treatment of glioblastoma, non-muscle invasive bladder cancer, and squamous and basal cell carcinoma.

WND spoke with the company's chief technology officer, Shlomo Nedvetski, at the annual COSM conference in Bellevue, Washington, hosted by the Discovery Institute.